My Profile
Felix Salmon
Unleashed on Reuters
Blogging the financial meltdown
See all posts
Wed 25 Nov 2009 | 21:24 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Hollis-Eden Pharmaceuticals Inc
Hollis-Eden Pharmaceuticals Inc (HEPH.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
HEPH
on other exchanges
As of 25 Nov 2009
0.52
USD
Price Change
+0.04
Percent Change
+7.81%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Dec 2008
Frincke, James
325,000
--
343,283
687,029
Hauer, Jerome
--
--
--
--
Marsella, Robert
248,000
--
161,465
417,276
Reading, Christopher
270,508
--
119,321
397,640
Sarni, Marc
--
--
--
--
Stickney, Dwight
371,394
--
116,639
495,844
Weber, Robert
235,000
--
186,741
429,552
Zizza, Salvatore
--
--
--
--
Find out more about HEPH.O
Insider Trading